Wilmingtonbiz logo
Print
Health Care

LabCorp To Buy Chiltern In $1.2B Deal

By Cece Nunn, posted Jul 31, 2017
Global life sciences company LabCorp is expected to acquire Chiltern, a contract research organization with North American headquarters in Wilmington, the companies announced Monday.

The acquisition depends on a definitive agreement with Chiltern’s shareholders in an all-cash transaction valued at about $1.2 billion. Once the transaction is complete, Chiltern will become part of LabCorp’s Covance segment. The combination of Covance and Chiltern will mean LabCorp can provide "leading oncology expertise" with services across all phases of drug development, company officials said in a presentation Monday morning.

“This acquisition strengthens our position as a leading life sciences company that delivers innovative diagnostics and drug development solutions to improve health and improve lives,” said David King, chairman and CEO of LabCorp (NYSE: LH), in the announcement. “Our acquisition of Covance has demonstrated the value of combining diagnostic and CRO capabilities, expertise, data and leadership. The addition of Chiltern furthers our strategy and will provide us with enhanced capabilities across a broader client base as we continue to innovate and grow.”

The all-cash transaction, which LabCorp expects to fund with a combination of bank financing and bonds, is expected to close in the fourth quarter of this year and is subject to regulatory approvals and customary closing conditions.

Asked in what way, if any, the change might affect Chiltern's Wilmington presence, Sue Maynard, vice president of corporate communication for LabCorp, said in an email, "Until the transaction closes, LabCorp and Chiltern will continue to operate as two separate companies and conduct business as usual. For the vast majority of employees, we expect to offer continued and potentially increased career opportunities."

Chiltern is one of more than 100 companies that make up the clinical research and biotechnology industry cluster in the Wilmington area, according to a report published by the N.C. Biotechnology Center. PPD, which had reportedly been a potential LabCorp acquisition earlier this year before new investors were announced in April, is the largest of the area's 30 or more CROs.

Chiltern has more than 4,500 employees around the world, including in the Asia-Pacific region, and has conducted more than 1,800 studies across 87 countries in the past five years, the release said.

According to the release, Chiltern is a leading CRO among emerging-to-mid biopharma customers, with forecasted 2017 revenue and adjusted EBITDA of about $550 million and $95 million, respectively, and a backlog of about $1 billion.

“Joining LabCorp and Covance will allow Chiltern to expand its collaborative approach to bring better, more personalized therapies to market for patients every day,” said Jim Esinhart, CEO of Chiltern. “Customers will benefit from the expanded capabilities this provides and our employees will have a greater opportunity to propel research into the future with strong, supportive partners.”

Since acquiring Covance, LabCorp has grown the CRO business to nearly $3 billion in annual revenue, said John Ratliff, CEO of Covance, in the release.

“We now join with Chiltern to create a market-leading CRO, with more than 20,000 talented employees around the world. The addition enhances Covance’s offerings as a major partner serving the top 20 biopharma segment and expands our current offering to include a dedicated focus on the high-growth emerging and mid-market biopharma segments," Ratliff said. "We are very pleased to welcome the Chiltern team to the LabCorp family as we work together to realize the promise of this unique and powerful combination.”

Join The Discussion

Similar Stories

Book On Business

Bob2017

The 2017 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!
Print Only
$24.95 - Qty
Print + Excel File
$79.95 - Qty

In The Current Issue

Info Junkie: Will Oden

Info Junkie Will Oden, attorney at Ward and Smith law firm, on his app and book picks.

Looking At The Big Picture

Every business, large and small, wants a blueprint for long-term growth. Wilmington-based Tayloe/Gray, a firm providing branding, design, te...

Homegrown T-shirts Wear Well Nationally

Who knew that a cat’s backside would strike a chord? The T-shirt design’s popularity has been a surprise to Leland resident Horace Long, own...

Ico topnews Editor's Picks

Jobs, Investment On The Rise Since 2012 In New Hanover County, Report Says

Christina Haley O'Neal - Sep 22, 2017

Session Seeks Workforce Training Input From Construction Employers

Cece Nunn - Sep 22, 2017

As One Gets Ready To Close, Other Area Golf Courses For Sale

Cece Nunn - Sep 21, 2017 Trending News

Gov. Cooper Vetos Bill That Includes Funding On GenX

Christina Haley O'Neal - Sep 21, 2017
Consulting

Action Coach Reggie Shropshire

I am a certified Wilmington Business Coach with ActionCOACH, the world’s number-one business coaching franchise.

Ico trending Trending News

Ico newsinimages News in Pictures

Have a tip, pitch or guest column?  Send us a tip.

Gallery Galleries

Video Videos

Power Breakfast: Coach C.B. McGrath - June 2017
Wilmington's Most Intriguing People of 2016

Register to Continue Seeing Wilmington's Best Business Coverage!


There are three ways to register for free.

Sign in with LinkedIn, Facebook or create an account:



Already registered? Login here.

Your free registration includes:

  • Access to 10 articles per month on WilmingtonBiz.com
  • Email updates to stay informed on local business news
  • A mobile optimized website
  • Advanced notification of Business Journal events
  • Management of your digital and print subscriptions
Laptop iphone ipad